Berger Montague

Recent News

CLASS ACTION REMINDER: Berger Montague Advises Altimmune, Inc. (ALT) Investors to Inquire About a Securities Fraud Lawsuit by October 6, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis) after a class action lawsuit was filed against Altimmune. Investor Deadline: Investors who purchased or...

2025-09-08 5:22 PM EDT

NYSE: KLC INVESTOR ALERT: Berger Montague Advises KinderCare Learning Companies, Inc. (KLC) Investors of an October 14, 2025 Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2025) - Berger Montague PC is investigating claims under the federal securities laws against KinderCare Learning Companies, Inc. (NYSE: KLC) ("KinderCare" or the "Company"), a provider of early childhood education and childcare services, after a class action lawsuit was filed against KinderCare. Investor Deadline: Investors who purchased or acquired KinderCare securities between October 6, 2024 to August 12, 2025 (the "Class Period"),...

2025-09-08 11:43 AM EDT

CLASS ACTION REMINDER: Berger Montague Advises CTO Realty Growth, Inc. (CTO) Investors to Inquire About a Securities Fraud Lawsuit by October 7, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - September 4, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of CTO between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities during the Class Period may, no later than...

2025-09-04 10:36 AM EDT

Sable Offshore Corp. (SOC) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Philadelphia, Pennsylvania--(Newsfile Corp. - September 4, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Sable Offshore Corp. (NYSE: SOC) ("Sable" or the "Company") following the filing of a securities class action lawsuit. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Sable securities between May 19, 2025 through June 3, 2025 (the "Class Period"), as well as on or traceable to the Company's May 2025...

2025-09-04 10:16 AM EDT

RXSIGHT (RXST) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by September 22, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - September 2, 2025) - Berger Montague PC, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). A class action lawsuit was recently filed on behalf of investors who acquired RxSight securities between November 7, 2024 and July 8, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired RxSight...

2025-09-02 5:37 PM EDT

Berger Montague PC Investigating Claims on Behalf of LifeMD, Inc. (LFMD) Investors After Class Action Filing

Philadelphia, Pennsylvania--(Newsfile Corp. - September 2, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be...

2025-09-02 12:06 PM EDT

INVESTOR ALERT: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - September 2, 2025) - National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Spectrum securities during the Class Period...

2025-09-02 11:54 AM EDT

CLASS ACTION REMINDER: Berger Montague Advises Novo Nordisk A/S (NVO) Investors to Inquire About a Securities Fraud Lawsuit by September 30, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - August 28, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, after a class action lawsuit was filed against Novo. Investor Deadline: Investors who purchased or acquired Novo securities between May 7, 2025 through July 28, 2025 (the "Class Period"), may, no later than September 30, 2025, seek...

2025-08-28 9:14 AM EDT

Berger Montague PC Investigating Claims on Behalf of C3.ai, Inc. (AI) Investors After Class Action Filing

Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against C3.ai, Inc. (NYSE: AI) ("C3.ai" or the "Company") on behalf of investors who purchased or acquired shares during the period from February 26, 2025 through August 8, 2025 (the "Class Period"), Investor Deadline: Investors who purchased or acquired C3.ai securities during the Class Period may, no later than October 21, 2025, seek to be...

2025-08-26 11:36 AM EDT

NASDAQ: ALT INVESTOR ALERT: Berger Montague Advises Altimmune, Inc. (ALT) Investors of an October 6, 2025 Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") following the filing of a securities class action lawsuit filed on behalf of investors who purchased or otherwise acquired Altimmune securities between August 10, 2023 through June 25, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired...

2025-08-26 11:20 AM EDT

CTO REALTY GROWTH SECURITIES FRAUD NOTICE: Berger Montague Informs CTO Realty Growth, Inc. (CTO) Investors of Securities Fraud Lawsuit

Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - Berger Montague PC is investigating claims under the federal securities laws against CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company"), a real estate investment trust (REIT) headquartered in Winter Park, Florida. Investor Deadline: Investors who purchased or acquired CTO securities between February 18, 2021 through June 24, 2025 (the "Class Period") may, no later than October 7, 2025, seek to be appointed as a lead...

2025-08-25 5:08 PM EDT

SABLE OFFSHORE CORP. (SOC) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By September 26, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Sable Offshore Corp. (NYSE: SOC) ("Sable" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Sable between May 19, 2025 through June 3, 2025 (the "Class Period"), including on or traceable to the Company's May 2025 secondary public offering. Berger Montague PC is investigating claims...

2025-08-25 10:36 AM EDT

FI CLASS ACTION NOTICE: Berger Montague Encourages Fiserv, Inc. (FI) Investors to Inquire About a Securities Fraud Class Action

Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - National plaintiffs' law firm Berger Montague PC is investigating potential claims against Fiserv, Inc. (NYSE: FI) ("Fiserv" or the "Company") related to alleged securities law violations. This investigation follows the filing of a securities class action lawsuit against Fiserv and certain of its senior executives on behalf of investors who purchased the Company's securities between July 24, 2024 and July 22, 2025 (the "Class...

2025-08-25 10:18 AM EDT

ATTENTION RXSIGHT (RXST) SHAREHOLDERS: Securities Fraud Lawsuit Filed Against RxSight, Inc

Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2025) - Berger Montague PC, a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST), following the recent filing of a federal securities class action lawsuit. The lawsuit alleges that Defendants failed to disclose to investors that: (1) RxSight was experiencing "adoption challenges" and/or structural issues resulting in...

2025-08-25 10:09 AM EDT

INVESTOR REMINDER: Berger Montague Notifies CTO Realty Growth, Inc. (CTO) Investors of a Class Action Lawsuit and Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of CTO between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities during the Class Period may, no later than...

2025-08-22 5:41 PM EDT

Altimmune, Inc. (ALT) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for obesity and liver disease, including MASH (metabolic dysfunction-associated steatohepatitis) after a class action lawsuit was filed against Altimmune. Investor Deadline: Investors who purchased or...

2025-08-22 10:52 AM EDT

SPECTRUM PHARMACEUTICALS (SPPI) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action

Philadelphia, Pennsylvania--(Newsfile Corp. - August 22, 2025) - National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Spectrum securities during the Class Period...

2025-08-22 10:47 AM EDT

INVESTOR ALERT: Berger Montague Advises Sable Offshore Corp. (SOC) Investors to Inquire About a Securities Fraud Class Action by September 26, 2025

Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Sable Offshore Corp. (NYSE: SOC) ("Sable" or the "Company") following the filing of a securities class action lawsuit. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Sable securities between May 19, 2025 through June 3, 2025 (the "Class Period"), as well as on or traceable to the Company's May 2025...

2025-08-21 5:46 PM EDT

CTO INVESTOR ALERT: Berger Montague Advises CTO Realty Growth, Inc. Investors of an October 7, 2025 Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Berger Montague PC is investigating potential securities fraud claims on behalf of investors of CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") following the filing of a securities class action lawsuit on behalf of investors who purchased or otherwise acquired CTO securities between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities...

2025-08-21 5:36 PM EDT

SHAREHOLDER ALERT: Berger Montague Reminds Novo Nordisk A/S (NVO) Investors of Class Action Lawsuit Deadline

Philadelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Novo from May 7, 2025 through July 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Novo securities during the Class Period may, no later than September 30,...

2025-08-21 5:16 PM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us